Primary sinonasal mucosal melanoma – Case report and literature review

1. Barnes L, Eveson JW. (eds.) WHO Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. IARCPress: Lyon; 2017.Search in Google Scholar

2. Aleksić A, Gajanin R, Djurdjević D, Novaković Z, Vranjes D, Spremo S, Travar D, Guzina-Golac N, Tomić-Spirić V. Melanoma of the sinonasal mucosa: A report on the two cases and a review of the literature. Vojnosanit Pregl. 2015;72(10):937-41.10.2298/VSP140414075ASearch in Google Scholar

3. Wagner M, Morris CG, Werning JW, Mendenhall WM. Mucosal melanoma of the head and neck. Am J Clin Oncol. 2008;31(1):43−8. DOI: 10.1097/COC.0b013e318134ee88.10.1097/COC.0b013e318134ee8818376227Search in Google Scholar

4. Seetharamu N, Ott PA, Pavlick AC. Mucosal melanomas: A case-based review of the literature. Oncologist. 2010;15(7):772−81. DOI: 10.1634/theoncologist.2010-0067. Epub 2010 Jun 22.10.1634/theoncologist.2010-0067.Epub2010Jun22Open DOISearch in Google Scholar

5. Dauer EH, Lewis JE, Rohlinger AL, Weaver AL, Olsen KD. Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg. 2008;138(3):347−52. DOI: 10.1016/j.otohns.2007.12.013.10.1016/j.otohns.2007.12.01318312883Open DOISearch in Google Scholar

6. Temam S, Mamelle G, Marandas P, Wibault P, Avril M, Janot F, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer. 2005;103(2):313−9.10.1002/cncr.2077515578718Search in Google Scholar

7. Carvajal RD, Spencer SA, Lydiatt W. Mucosal melanoma: a clinically and biologically unique disease entity. J Natl Compr Canc Netw. 2012;10(3):345-56.10.6004/jnccn.2012.003422393195Search in Google Scholar

8. Schaefer T, Satzger I, Gutzmer R. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients. Medicine (Baltimore). 2017;96(1):e5753. DOI: 10.1097/MD.0000000000005753.10.1097/MD.0000000000005753522867728072717Search in Google Scholar

9. Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M.D. Anderson Cancer Center. Cancer. 2010;116(9):2215-23. DOI: 10.1002/cncr.24976.10.1002/cncr.2497620198705Open DOISearch in Google Scholar

10. Alves IS, Berriel LG, Alves RT, Pinto MB, Oliveira CF, Cazzotto AC, et al. Sinonasal Melanoma: A Case Report and Literature Review. Case Rep Oncol Med. 2017;2017:8201301. DOI: 10.1155/2017/8201301. Epub 2017 Jan 31.10.1155/2017/8201301530697528255482Search in Google Scholar

11. Lincoln RP. A case of melano-sarcoma of the nose cured by galvanocauterization. N Y Med J. 1885;42:406–7.Search in Google Scholar

12. Gilain L, Houette A, Montalban A, Mom T, Saroul N. Mucosal melanoma of the nasal cavity and paranasal sinuses. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2014;131(6):365-9.10.1016/j.anorl.2013.11.00424906226Search in Google Scholar

13. Wong JH, Cagle LA, Storm FK, Morton DL. Natural history of surgically treated mucosal melanoma. Am J Surg. 1987;154(1):54-7.10.1016/0002-9610(87)90289-3Search in Google Scholar

14. Axéll T, Hedin CA. Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits. Scand J Dent Res. 1982;90(6):434–42.Search in Google Scholar

15. Göde S, Turhal G, Tarhan C, Yaman B, Kandiloğlu G, Öztürk K, et al. Primary Sinonasal Malignant Melanoma: Effect of Clinical and Histopathologic Prognostic Factors on Survival. Balkan Med J. 2017;34(3):255-62. DOI: 10.4274/balkanmedj.2016.0503. Epub 2017 Apr 6.10.4274/balkanmedj.2016.0503.Epub2017Apr6Open DOISearch in Google Scholar

16. Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Critical Reviews in Oncology / Hematology. 2017;112:136-52. DOI: 10.1016/j.critrevonc.2017.01.019.10.1016/j.critrevonc.2017.01.019Open DOISearch in Google Scholar

17. Saint-Blancard P, Kossowski M. Mélanomes des muqueuses nasosinusiennes. Presse Med. 2006;35(11 Part 1):1664–7.10.1016/S0755-4982(06)74876-XSearch in Google Scholar

18. Keraliya AR, Krajewski KM, Braschi-Amirfarzan M, et al. Extracutaneous melanomas: a primer for the radiologist. Insights Imaging. 2015;6(6):707-17. DOI: 10.1007/s13244-015-0427-8.10.1007/s13244-015-0427-8465623026334521Open DOISearch in Google Scholar

19. Yoshioka H, Kamada T, Kandatsu S, Koga M, Yoshikawa K, Matsuoka Y, et al. MRI of mucosal malignant melanoma of the head and neck. J Comput Assist Tomogr. 1998;22(3):492–7.10.1097/00004728-199805000-000249606394Search in Google Scholar

20. Snyder ML, Paulino AF. Melan-A as a useful diagnostic immunohistochemical stain for the diagnosis of primary sinonasal melanomas. Head Neck. 2002;24(1):52-5.10.1002/hed.1000711774402Search in Google Scholar

21. Yu CH, Chen HH, Liu CM, Jeng YM, Wang JT, Wang YP, et al. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas. J Oral Pathol Med. 2005;34(9):540–5.10.1111/j.1600-0714.2005.00340.x16138892Open DOISearch in Google Scholar

22. Bishop PW. An immunohistochemical vademecum. Available at http://e-immunohistochemistry.info/web/histopathology_help.htm. Version date October 2012.Search in Google Scholar

23. Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol. 2001;25(6):782-7.10.1097/00000478-200106000-0001011395556Open DOISearch in Google Scholar

24. Weinstein D, Leininger J, Hamby C, Safai B. Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol. 2014;7(6):13-24.Search in Google Scholar

25. Modabbernia S, Bashardoust N, Bagheri SS. Malignant Mucosal Melanoma of the Maxillary Sinus. Journal of Dentomaxillofacial Radiology, Pathology and Surgery. 2017;5(4):32-6.10.18869/acadpub.3dj.5.4.32Search in Google Scholar

26. Nonaka D, Chiriboda L, Rubin BP. SOX10: a pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008;32(9):1291–8. DOI: 10.1097/PAS.0b013e3181658c14.10.1097/PAS.0b013e3181658c1418636017Search in Google Scholar

27. Gershon TR, Oppenheimer O, Chin SS, Gerald WL. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia. 2005;7(6):575–84.10.1593/neo.04637150128616036108Open DOISearch in Google Scholar

28. Kelsch RN. Sorting out SOX10 functions in neural crest development. Bioessays. 2006;28(8):788-98.10.1002/bies.2044516927299Search in Google Scholar

29. Liu HG, Kong MX, Yao Q, Wang SY, Shibata R, Yee H, et al. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population. Head Neck Pathol. 2012;6(4):401–8. DOI: 10.1007/s12105-012-0375-2. Epub 2012 Jun 27.10.1007/s12105-012-0375-2350089622736149Search in Google Scholar

30. Jennings C, Kim J. Identification of nodal metastases in melanoma using sox-10. Am J Dermatopathol. 2011;33(5):474–82. DOI: 10.1097/DAD.0b013e3182042893.10.1097/DAD.0b013e318204289321552103Search in Google Scholar

31. Medina JE, Ferlito A, Pellitteri PK, Shaha AR, Khafif A, Devaney KO, et al. Current management of mucosal melanoma of the head and neck. J Surg Oncol. 2003;83(2):116–22.10.1002/jso.1024712772206Open DOISearch in Google Scholar

32. Zebary A, Jangard M, Omholt K. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases. Br J Cancer. 2013;109(3):559-64. DOI: 10.1038/bjc.2013.373. Epub 2013 Jul 16.10.1038/bjc.2013.373.Epub2013Jul16Open DOISearch in Google Scholar

33. Sullivan RJ, Flaherty K. MAP kinase signaling and inhibition in melanoma. Oncogene. 2013;32(19):2373–9. DOI: 10.1038/onc.2012.345. Epub 2012 Sep 3.10.1038/onc.2012.345.Epub2012Sep3Open DOISearch in Google Scholar

34. Turri–Zanoni M, Medicina D, Lombardi D, Ungari M, Balzarini P, Rossini C, et al. Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases. Head Neck. 2013;35(8):1066-77. DOI: 10.1002/hed.23079. Epub 2012 Jul 12.10.1002/hed.2307922791410Search in Google Scholar

35. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507–16. DOI: 10.1056/NEJMoa1103782.10.1056/NEJMoa1103782354929621639808Open DOISearch in Google Scholar

36. Hauschild A, Grob JJ, Demidov LV, Jouray T, Gutzmer R, Millward M, et al. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, openlabel, phase 3 randomised controlled trial. Lancet. 2012;380(9839):358–65. DOI: 10.1016/S0140-6736(12)60868-X. Epub 2012 Jun 25.10.1016/S0140-6736(12)60868-X.Epub2012Jun25Open DOISearch in Google Scholar

37. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. (Eds.). AJCC Cancer Staging Manual. Eighth Edition. Springer International Publishing; 2017.Search in Google Scholar

38. Enee V, Houliat T, Truilhe Y, Darrouzet V, Stoll D. Malignant melanoma of the nasosinal mucosa. Retrospective study apropos of 20 cases. Rev Laryngol Otol Rhinol (Board). 2000;121(4):243–50.Search in Google Scholar

39. Clifton N, Harrison L, Bradley PJ, Jones NS. Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol. 2011;125(5):479–85. DOI: 10.1017/S0022215110002720. Epub 2011 Jan 21.10.1017/S0022215110002720.Epub201121Open DOISearch in Google Scholar

40. Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, et al. Mucosal Melanoma of the Head and Neck: Clinical Practice Guidelines in Oncology. JNCCN. 2012;10(3):320-38.Search in Google Scholar

41. Dirix P, Vanstraelen B, Jorissen M, Vander Poorten V, Nuyts S. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(4):998–1004. DOI: 10.1016/j.ijrobp.2009.09.067. Epub 2010 Mar 24.10.1016/j.ijrobp.2009.09.067.Epub201024Open DOISearch in Google Scholar

42. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664-78.10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-GSearch in Google Scholar

43. Khan MN, Kanumuri VV, Raikundalia MD, et al. Sinonasal melanoma: survival and prognostic implications based on site of involvement. Int Forum Allergy Rhinol. 2014;4(2):151-5. DOI: 10.1002/alr.21243. Epub 2013 Nov 4.10.1002/alr.21243.Epub2013Nov4Open DOISearch in Google Scholar

44. Gore MR, Zanation AM. Survival in Sinonasal Melanoma: A Meta-analysis. J Neurol Surg B Skull Base. 2012;73(3):157-62. DOI: 10.1055/s-0032-1301400.10.1055/s-0032-1301400Open DOISearch in Google Scholar

45. Bachar G., Loh KS, O’Sullivan B, et al. Mucosal melanomas of head and neck: experience of the Princess Margaret Hospital. Head Neck. 2008;30(10):1325-31. DOI: 10.1002/hed.20878.10.1002/hed.20878Search in Google Scholar